Skip to content

Clinical trials

Non-ST Elevated Myocardial Infarction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-ST Elevated Myocardial Infarction Country / region: Russia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20141
20161
20171
20181
20191
20202

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline2
Penza State University2
Anthera Pharmaceuticals1
Biotronik Russia1
I.M. Sechenov First Moscow State Medical University1
National Research Center for Preventive Medicine1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-ST Elevated Myocardial Infarction9
ST Elevation Myocardial Infarction7
Acute Coronary Syndrome3
Angina, Unstable3
Coronary Artery Disease2
Myocardial Infarction2
Acute Kidney Injury1
Angina Pectoris1
Angina, Stable1
COVID-191

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.